...
Stock Price Target CVS.
| High | $127.00 |
|---|---|
| Median | $119.00 |
| Low | $98.00 |
| Average | $116.45 |
| Current Price | $95.68 |
What is the price targets for CVS Health stock?
The average twelve-month price target for CVS Health is $112.37 with a high price target of $125.00 and a low price target of $93.00. Learn more Do Wall Street analysts like CVS Health more than its competitors?
Is CVS Health a buy or sell on Wall Street?
According to the issued ratings of 21 analysts in the last year, the consensus rating for CVS Health stock is Buy based on the current 4 hold ratings, 16 buy ratings and 1 strong buy rating for CVS. The average twelve-month price target for CVS Health is $112.37 with a high price target of $125.00 and a low price target of $93.00. Learn more
What is the upside for CVS Corporation (CVS)?
Their average twelve-month price target is $75.39, suggesting that the stock has a possible upside of 13.27%. The high price target for CVS is $95.00 and the low price target for CVS is $61.00.
Do analysts like CVS Health stock more than other retail/wholesale companies?
Analysts like CVS Health stock more than the stock of other Retail/Wholesale companies. The consensus rating score for CVS Health is 2.86 while the average consensus rating score for retail/wholesale companies is 2.53. Learn more Do MarketBeat users like CVS Health more than its competitors?
What are analysts saying about CVS stock?
The 22 analysts offering 12-month price forecasts for CVS Health Corp have a median target of 119.00, with a high estimate of 127.00 and a low estimate of 98.00. The median estimate represents a +25.22% increase from the last price of 95.03.
Is CVS stock a buy or sell?
CVS Health has received a consensus rating of Buy. The company's average rating score is 2.79, and is based on 15 buy ratings, 4 hold ratings, and no sell ratings.
Is CVS good to invest in?
CVS Health is witnessing a positive estimate revision trend for 2022. In the past 90 days, the Zacks Consensus Estimate for its earnings has moved 0.4% north to $8.26. The Zacks Consensus Estimate for its first-quarter 2022 revenues is pegged at $75.17 billion, suggesting 8.8% growth from the year-ago reported number.
What is the analyst price target?
A price target is a price at which an analyst believes a stock to be fairly valued relative to its projected and historical earnings. When an analyst raises their price target for a stock, they generally expect the stock price to rise.
Is CVS undervalued?
CVS' sales looks to remain consistent throughout the volatile economic cycle. The company is operating efficiently considering its EBITDA relative to resources at disposal. Its stock is undervalued relative to its industry peers, which aligns well with the market's search for value over growth.
Is CVS overvalued?
Investors may also note in 2020 and 2021, Walgreens' EV-to-EBITDA ratio was about one or two turns higher than CVS Health. When compared to Walgreens, CVS does not appears overvalued....Comps With Walgreens.CVSWalgreensP / FCF12.1x13.4x2 more rows•Apr 5, 2022
Why you should buy CVS stock?
Key Growth Catalysts According to the company's fourth-quarter update, CVS.com is one of the top health websites with more than 2 billion visits in 2021, up nearly 55% over the prior year. The company now serves 40 million customers digitally, up approximately 10% in the last six months.
Which is a better stock CVS or Walgreens?
So which stock should you go with? Although CVS is more diverse and slightly more profitable, the difference isn't significant; Walgreens looks to be the better investment all around. Its dividend pays more, and the company is investing in primary care, which should help lead to even more traffic at its stores.
Is CVS a good dividend stock?
To conclude, CVS is a solid dividend growth company. The company enjoys top and bottom-line growth. After paying some long-term debt, the balance sheet is stronger, and the company is returning more capital to its patient shareholders.
How far out are analyst price targets?
Essentially, analyst price targets aim to forecast what a stock might be worth after a certain span of time, usually a year to 18 months. While the hit/miss ratio of these targets is not 100 percent, the majority of forecasts among sell-side analysts meet or exceed the target within 12 months.
How often are analyst price targets correct?
Based on their 2012 study of more than 11,000 analysts from 41 countries, the overall accuracy of target prices is not very high, averaging around 18% for a three-month horizon and 30% for a 12-month horizon.
Who is the most accurate stock analyst?
Topping our list this year is John Gerdes of MKM Partners, who is the acting managing director of the firm. Through his highly accurate stock ratings, Gerdes has achieved the best rank, weighted by his ratings success and average return percentages.
Is CVS a good stock to buy 2022?
"We expect the retail business to slow in 2022 as COVID vaccinations and testing decline, but the CVS Pharmacy remains one of the company's greatest and most visible assets as it enlarges its national footprint in the community-based primary care market," France wrote.
Why should I buy CVS stock?
CVS Health is witnessing a positive estimate revision trend for 2022. In the past 90 days, the Zacks Consensus Estimate for its earnings has moved 0.4% north to $8.26. The Zacks Consensus Estimate for its first-quarter 2022 revenues is pegged at $75.17 billion, suggesting 8.8% growth from the year-ago reported number.
Is CVS a good dividend stock?
To conclude, CVS is a solid dividend growth company. The company enjoys top and bottom-line growth. After paying some long-term debt, the balance sheet is stronger, and the company is returning more capital to its patient shareholders.
What is CVS Health's consensus rating and price target?
According to the issued ratings of 18 analysts in the last year, the consensus rating for CVS Health stock is Buy based on the current 4 hold ratin...
Do Wall Street analysts like CVS Health more than its competitors?
Analysts like CVS Health stock more than the stock of other Retail/Wholesale companies. The consensus rating score for CVS Health is 2.78 while the...
Do MarketBeat users like CVS Health more than its competitors?
MarketBeat users like CVS Health stock more than the stock of other Retail/Wholesale companies. 77.47% of MarketBeat users gave CVS Health an outpe...
Is CVS Health being downgraded by Wall Street analysts?
Over the previous 90 days, CVS Health's stock had 2 downgrades by analysts.
Does CVS Health's stock price have much upside?
According to analysts, CVS Health's stock has a predicted upside of 16.63% based on their 12-month price targets.
What analysts cover CVS Health?
CVS Health has been rated by Deutsche Bank Aktiengesellschaft , Sanford C. Bernstein , and Tigress Financial in the past 90 days.
What is CVS’s average 12-month price target, according to analysts?
Based on analyst ratings, CVS Health’s 12-month average price target is $116.45.
What is CVS’s upside potential, based on the analysts’ average price target?
CVS Health has 18.77% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the [object Object] tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the [object Object] and follow the analysts of your choice. Visit their profiles for more details a...
Component Grades
We have 9 different ratings for every stock to help you appreciate its future potential. You can unlock it all now.
The Trend in the Analyst Price Target
CVS's average price target has moved up $29.18 over the prior 14 months.
The Trend in the Broker Recommendations
Over the past 35 weeks, CVS's average broker recommendation rating improved by 0.46.
Stock Price Forecast
The 23 analysts offering 12-month price forecasts for CVS Health Corp have a median target of 120.00, with a high estimate of 125.00 and a low estimate of 98.00. The median estimate represents a +19.75% increase from the last price of 100.21.
Analyst Recommendations
The current consensus among 27 polled investment analysts is to Buy stock in CVS Health Corp. This rating has held steady since February, when it was unchanged from a Buy rating. Move your mouse over past months for detail
CVS Group (OTCMKTS:CVSGF) Price Target and Consensus Rating
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy).
Analyst Price Target Consensus
Sign-up to receive the latest news and ratings for CVSGF and its competitors with MarketBeat's FREE daily newsletter.
Analyst Ratings By Month
The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Average Share Price and Price Target by Month
The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target.
CVS Group (OTCMKTS:CVSGF) Analyst Ratings Frequently Asked Questions
According to the issued ratings of 2 analysts in the last year, the consensus rating for CVS Group stock is Buy based on the current 1 hold rating and 1 buy rating for CVSGFthe . Learn more on CVSGF's analyst rating history
